Sphera Funds Management »

Celldex Therapeutics shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $17M 431k 39.66
2023-09-30 $7.7M 280k 27.52
2023-06-30 $5.4M 160k 33.93
2021-12-31 $6.4M 167k 38.64
2021-09-30 $7.0M 130k 53.99
2021-03-31 $4.5M 220k 20.60
2020-12-31 $11M 597k 17.52
2020-09-30 $5.5M 370k 14.83